NCT00504153View on ClinicalTrials.gov

Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon CancerStage IV Rectal Cancer
Interventions
DRUG

dasatinib

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00504153 - Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter